TY - JOUR

T1 - Assessment of the control measures for category A diseases of Animal Health Law: Contagious Bovine Pleuropneumonia

AU - EFSA Panel on Animal Health and Welfare, null

AU - Nielsen, Søren Saxmose

AU - Alvarez, Julio

AU - Bicout, Dominique Joseph

AU - Calistri, Paolo

AU - Canali, Elisabetta

AU - Drewe, Julian Ashley

AU - Garin-Bastuji, Bruno

AU - Gonzales Rojas, José Luis

AU - Gortázar, Christian

AU - Herskin, Mette

AU - Michel, Virginie

AU - Miranda Chueca, Miguel Ángel

AU - Padalino, Barbara

AU - Pasquali, Paolo

AU - Spoolder, Hans

AU - Ståhl, Karl

AU - Velarde, Antonio

AU - Viltrop, Arvo

AU - Winckler, Christoph

AU - Gubbins, Simon

AU - Stegeman, Jan Arend

AU - Thiaucourt, François

AU - Antoniou, Sotiria-Eleni

AU - Aznar, Inma

AU - Papanikolaou, Alexandra

AU - Zancanaro, Gabriele

AU - Roberts, Helen Clare

N1 - https://doi.org/10.2903/j.efsa.2022.7067

PY - 2022

Y1 - 2022

N2 - Abstract EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases (?Animal Health Law?). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Contagious Bovine Pleuropneumonia (CBPP). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period, (iii) the minimum radius of the protection and surveillance zones, and (iv) the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different clinical and laboratory sampling procedures are proposed depending on the scenarios considered. The monitoring period of 45?days was assessed as not effective and at least 90?days (3?months) is recommended in affected areas where high awareness is expected; when the index case occurs in an area where the awareness is low the monitoring period should be at least 180?days (6?months). Since transmission kernels do not exist and data to estimate transmission kernels are not available, the effectiveness of surveillance and protection zones for CBPP was based on expert knowledge. A surveillance zone of 3?km was considered effective, while a protection zone including establishments adjacent to affected ones is recommended. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CBPP.

AB - Abstract EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases (?Animal Health Law?). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Contagious Bovine Pleuropneumonia (CBPP). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period, (iii) the minimum radius of the protection and surveillance zones, and (iv) the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different clinical and laboratory sampling procedures are proposed depending on the scenarios considered. The monitoring period of 45?days was assessed as not effective and at least 90?days (3?months) is recommended in affected areas where high awareness is expected; when the index case occurs in an area where the awareness is low the monitoring period should be at least 180?days (6?months). Since transmission kernels do not exist and data to estimate transmission kernels are not available, the effectiveness of surveillance and protection zones for CBPP was based on expert knowledge. A surveillance zone of 3?km was considered effective, while a protection zone including establishments adjacent to affected ones is recommended. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CBPP.

KW - Contagious Bovine Pleuropneumonia

KW - Disease control measures

KW - Mycoplasma mycoides subsp. mycoides

KW - sampling procedures

KW - monitoring period

KW - protection zone

KW - surveillance zone

U2 - 10.2903/j.efsa.2022.7067

DO - 10.2903/j.efsa.2022.7067

M3 - Journal article

C2 - 35079288

VL - 20

SP - 1

EP - 96

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

IS - 1

M1 - e07067

ER -